AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Outset Medical, Inc. Director's Dealing 2021

Mar 18, 2021

33476_dirs_2021-03-18_4515787b-3e2e-4a68-a88d-52115b07f6aa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Outset Medical, Inc. (OM)
CIK: 0001484612
Period of Report: 2021-03-15

Reporting Person: Brottem John L. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-15	Stock Option (Right to Buy)	$50.01	A	22209	Acquired	2031-03-14	Common Stock (22209)	Direct

Footnotes

F1: This option vests 25% on March 15, 2022, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

F2: This Form 4 amendment is being filed to correct the exercise price.